Department of Geriatrics, Fuxing Hospital, affiliated to Capital Medical University, Beijing, China,
General Practice Ward, Fuxing Hospital, affiliated to Capital Medical University, Beijing, China.
Clin Interv Aging. 2018 Dec 31;14:81-90. doi: 10.2147/CIA.S187757. eCollection 2019.
Studies have shown that increases in low-level high-sensitivity cardiac troponin T (hs-cTnT) and N-terminal prohormone brain natriuretic peptide (NT-proBNP) in the elderly population lead to high risk of adverse clinical outcomes, such as mortality. In this study, associations between the two biomarkers and long-term mortality in elderly patients hospitalized for medical conditions other than acute cardiovascular events were investigated. A comparison of the predictive value of hs-cTnT and NT-proBNP for all-cause mortality was conducted.
A cohort of 715 elderly inpatients free of acute cardiovascular events was initially recruited. Based on tertiles of baseline hs-cTnT and NT-proBNP levels, the elderly were arranged into low, middle, and high groups. The mortality of each group was observed and the predictive values of hs-cTnT and NT-proBNP compared. Additionally, all-cause mortality was analyzed for hs-cTnT and NT-proBNP combined.
There were 135 (18.9%) all-cause mortality cases identified during follow-up (median 47 months). The upper tertile of hs-cTnT was significantly associated with an increased risk of mortality (HR 3.29, 95% CI 1.85-5.85), even after adjustment for potential confounders. However, there were no significant differences observed in mortality rates among the three NT-proBNP groups after adjustment for potential confounders (HR 1.77, 95% CI 0.83-3.17). Compared to NT-proBNP, hs-cTnT was a better predictor of mortality, as area under curves for hs-cTnT and NT-proBNP at 60 months were 0.712 (95% CI 0.616-0.809) and 0.585 (95% CI 0.483-0.6871), respectively. Also, the combination of the two cardiac biomarkers did not render a better predictive value for mortality than hs-cTnT alone.
Unlike hs-cTnT, baseline NT-proBNP levels failed to show an independent association with all-cause mortality in hospitalized elderly without acute cardiovascular events. hs-cTnT provided significant prognostic value for mortality in the study cohort.
研究表明,老年人低水平高敏心肌肌钙蛋白 T(hs-cTnT)和 N 端脑利钠肽前体(NT-proBNP)的升高与不良临床结局(如死亡率)的高风险相关。在这项研究中,研究了这两种生物标志物与因非急性心血管事件住院的老年患者的长期死亡率之间的关系。比较了 hs-cTnT 和 NT-proBNP 对全因死亡率的预测价值。
最初招募了 715 名无急性心血管事件的老年住院患者。根据基线 hs-cTnT 和 NT-proBNP 水平的三分位数,将老年人分为低、中、高组。观察每组的死亡率,并比较 hs-cTnT 和 NT-proBNP 的预测值。此外,还分析了 hs-cTnT 和 NT-proBNP 联合的全因死亡率。
在随访期间(中位 47 个月)发现 135 例(18.9%)全因死亡病例。hs-cTnT 的上三分位数与死亡率升高显著相关(HR 3.29,95%CI 1.85-5.85),即使在调整了潜在混杂因素后也是如此。然而,在调整了潜在混杂因素后,NT-proBNP 三组之间的死亡率没有显著差异(HR 1.77,95%CI 0.83-3.17)。与 NT-proBNP 相比,hs-cTnT 是死亡率的更好预测指标,因为 hs-cTnT 和 NT-proBNP 在 60 个月时的曲线下面积分别为 0.712(95%CI 0.616-0.809)和 0.585(95%CI 0.483-0.6871)。此外,这两种心脏生物标志物的组合并没有比单独使用 hs-cTnT 提供更好的死亡率预测价值。
与 hs-cTnT 不同,基线 NT-proBNP 水平与无急性心血管事件住院的老年患者的全因死亡率之间没有独立关联。hs-cTnT 为研究队列的死亡率提供了显著的预后价值。